Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda

Vaccine

Volumn 29, Issue 19, 2011, Pages 3564-3570

  Fadnes, Lars T ^a   Nankabirwa, Victoria ^b   Sommerfelt, Halvor ^a,c   Tylleskär, Thorkild ^a   Tumwine, James K ^b   Engebretsen, Ingunn M S ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b MAKERERE UNIVERSITY   (Uganda)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Immunisation; Mass vaccination; Sub Saharan Africa; Uganda; Vaccination coverage; Vaccination timeliness

Indexed keywords

BCG VACCINE; GADOLINIUM PENTETATE ALBUMIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES VACCINE; ORAL POLIOMYELITIS VACCINE; RETINOL;

AGE SPECIFIC CARE; ARTICLE; BCG VACCINATION; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; FEMALE; HAEMOPHILUS INFLUENZAE; HEALTH EDUCATION; HUMAN; INFANT; INFLUENZA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; NEWBORN; PERTUSSIS; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA; TETANUS; UGANDA; VACCINATION;

CHILD; CLINICAL TRIALS AS TOPIC; CLUSTER ANALYSIS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; KAPLAN-MEIER ESTIMATE; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UGANDA; VACCINATION; VACCINES; VITAMIN A;

EID: 79954992707     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.093     Document Type: Article

References (41)

1. Grant C.C., Roberts M., Scragg R., Stewart J., Lennon D., Kivell D., et al. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. Br Med J 2003, 326(April (7394)):852-853.
2. Kolos V., Menzies R., McIntyre P. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination. Vaccine 2007, 25(January (4)):588-590.
3. Heininger U., Zuberbuhler M. Immunization rates and timely administration in pre-school and school-aged children. Eur J Pediatr 2006, 165(February (2)):124-129.
4. von Kries R., Bohm O., Windfuhr A. Haemophilus influenzae b-vaccination: the urgency for timely vaccination. Eur J Pediatr 1997, 156(April (4)):282-287.
5. Breiman R.F., Streatfield P.K., Phelan M., Shifa N., Rashid M., Yunus M. Effect of infant immunisation on childhood mortality in rural Bangladesh: analysis of health and demographic surveillance data. Lancet 2004, 364(December (9452)):2204-2211.
6. Akmatov M.K., Kretzschmar M., Kramer A., Mikolajczyk R.T. Timeliness of vaccination and its effects on fraction of vaccinated population. Vaccine 2008, 26(July (31)):3805-3811.
7. Dayan G.H., Shaw K.M., Baughman A.L., Orellana L.C., Forlenza R., Ellis A., et al. Assessment of delay in age-appropriate vaccination using survival analysis. Am J Epidemiol 2006, 163(March (6)):561-570.
8. Clark A., Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009, 373(May (9674)):1543-1549.
9. Luman E.T., Barker L.E., Shaw K.M., McCauley M.M., Buehler J.W., Pickering L.K. Timeliness of childhood vaccinations in the United States - days undervaccinated and number of vaccines delayed. J Am Med Assoc 2005, 293(March (10)):1204-1211.
10. Shann F., Nohynek H., Scott J.A., Hesseling A., Flanagan K.L. Randomized trials to study the nonspecific effects of vaccines in children in low-income countries. Pediatr Infect Dis J 2010, 29(May (5)):457-461.
11. Ndiritu M., Cowgill K.D., Ismail A., Chiphatsi S., Kamau T., Fegan G., et al. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type B and hepatitis B virus antigens. BMC Public Health 2006, 6:132.
12. Nankunda J., Tylleskar T., Ndeezi G., Semiyaga N., Tumwine J.K. Establishing individual peer counselling for exclusive breastfeeding in Uganda: implications for scaling-up. Matern Child Nutr 2010, 6(January (1)):53-66.
13. Uganda Bureau of Statistics. 2010. Available from: http://www.ubos.org/.
14. Uganda Ministry of Health Uganda HIV/AIDS Sero-Behavioral Survey 2004-2005 2006, O. Macro (Ed.).
15. Uganda Ministry of Health, UNICEF, WHO Promotion of immunisation in Uganda: booklet for leaders 2002, Uganda Ministry of Health (Ed.).
16. Laubereau B., Hermann M., Schmitt H.J., Weil J., von Kries R. Detection of delayed vaccinations: a new approach to visualize vaccine uptake. Epidemiol Infect 2002, 128(April (2)):185-192.
17. Howe L.D., Hargreaves J.R., Huttly S.R. Issues in the construction of wealth indices for the measurement of socio-economic position in low-income countries. Emerg Themes Epidemiol 2008, 5:3.
18. Uganda Bureau of Statistics. 2010. Available from: http://www.ubos.org/.
19. WHO WHO-UNICEF estimates of coverage 2008, Available from: http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tswucoveragedtp1.htm [cited 2010-10-11].
20. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(June (9730)):1969-1987.
21. Biellik R., Madema S., Taole A., Kutsulukuta A., Allies E., Eggers R., et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002, 359(May (9317)):1564-1568.
22. Sudfeld C.R., Navar A.M., Halsey N.A. Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol 2010, 39(April (Suppl. 1)):i48-55.
23. Orenstein W.A., Strebel P.M., Papania M., Sutter R.W., Bellini W.J., Cochi S.L. Measles eradication: is it in our future?. Am J Public Health 2000, 90(October (10)):1521-1525.
24. Stittelaar K.J., de Swart R.L., Osterhaus A.D. Vaccination against measles: a neverending story. Expert Rev Vaccines 2002, 1(August (2)):151-159.
25. Dai B., Chen Z.H., Liu Q.C., Wu T., Guo C.Y., Wang X.Z., et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 1991, 69(4):415-423.
26. Strebel P., Cochi S., Grabowsky M., Bilous J., Hersh B.S., Okwo-Bele J.M., et al. The unfinished measles immunization agenda. J Infect Dis 2003, 187(May (Suppl. 1)):S1-S7.
27. Kroger A.T., Atkinson W.L., Marcuse E.K., Pickering L.K. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(December (RR-15)):1-48.
28. Beaton G, Martorell R, Aronson K, Edmonston B, McCabe G, Ross AC, et al. Effectiveness of vitamin A supplementation in the control of young child morbidity and mortality in developing countries. Discussion Paper No. 13. United Nations - Administrative Committee on Coordination - Subcommittee on Nutrition (ACC/SCN); 1993.
29. Gogia S., Sachdev H.S. Neonatal vitamin A supplementation for prevention of mortality and morbidity in infancy: systematic review of randomised controlled trials. BMJ 2009, 338:b919.
30. Klemm R.D., Labrique A.B., Christian P., Rashid M., Shamim A.A., Katz J., et al. Newborn vitamin A supplementation reduced infant mortality in rural Bangladesh. Pediatrics 2008, 122(July (1)):e242-e250.
31. Benn C.S., Diness B.R., Roth A., Nante E., Fisker A.B., Lisse I.M., et al. Effect of 50,000IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008, 336(June (7658)):1416-1420.
32. Efficacy of newborn vitamin A supplementation versus placebo in improving child survival (NeoVitA Trial) 2010, Available from http://clinicaltrials.gov/ct2/show/NCT01138449?term=Bhandari&rank=1.
33. Rwashana A.S., Williams D.W., Neema S. System dynamics approach to immunization healthcare issues in developing countries: a case study of Uganda. Health Informatics J 2009, 15(June (2)):95-107.
34. Andersen R.M. National health surveys and the Behavioral Model of Health Services Use. Med Care 2008, 46(July (7)):647-653.
35. Ndiritu M., Cowgill K.D., Ismail A., Chiphatsi S., Kamau T., Fegan G., et al. Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type B and hepatitis B virus antigens. BMC Public Health 2006, 17(May (6)):132.
36. Jacobson V.J., Szilagyi P. Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005, 20(July (3)):CD003941.
37. OMEVAC - Open Mobile Electronic Vaccine Trials. 2010. Available from: [cited 2010-10-05]. http://www.openxdata.org/Main/OMEVAC.
38. Grabowsky M., Nobiya T., Ahun M., Donna R., Lengor M., Zimmerman D., et al. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage. Bull World Health Organ 2005, 83(March (3)):195-201.
39. Nankabirwa V., Tylleskar T., Tumwine J.K., Sommerfelt H. Maternal education is associated with vaccination status of infants less than 6 months in Eastern Uganda: a cohort study. BMC Pediatr 2010, 10:92.
40. Meheus F., Van Doorslaer E. Achieving better measles immunization in developing countries: does higher coverage imply lower inequality?. Soc Sci Med 2008, 66(April (8)):1709-1718.
41. Jensen H., Benn C.S., Lisse I.M., Rodrigues A., Andersen P.K., Aaby P. Survival bias in observational studies of the impact of routine immunizations on childhood survival. Trop Med Int Health 2007, 12(January (1)):5-14.